Literature DB >> 7785472

Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.

Y F Ma1, W S Jee, H Z Ke, B Y Lin, X G Liang, M Li, N Yamamoto.   

Abstract

The purpose of this study was to determine if human parathyroid hormone-(1-38) (hPTH(1-38)) can restore cancellous bone mass to the established osteopenic, immobilized proximal tibial metaphyses of female rats. The right hindlimbs of 6-month-old female Sprague-Dawley rats were immobilized by bandaging the right hindlimbs to the abdomen. After 30 days of right hindlimb immobilization, the rats were subcutaneously injected with 200 micrograms hPTH(1-38)/kg/day for 15 days (short-term treatment) or 75 days (longer-term treatment). Static bone histomorphometry was performed on the primary spongiosa, and both static and dynamic histomorphometry were performed on the secondary spongiosa of the right proximal tibial metaphyses. Immobilization for 30 days without treatment decreased trabecular bone area, number, and thickness in both primary and secondary spongiosa, and induced an increase in eroded perimeter and a decrease in tissue referent-bone formation rate in the secondary spongiosa. These changes reached a new steady state thereafter. Treatment with 200 micrograms hPTH(1-38)/kg/day for 15 days, beginning 30 days after immobilization, significantly increased trabecular bone area, thickness, and number in both primary and secondary spongiosa despite continuous immobilization when compared with controls. The short-term PTH treatment (15 days) significantly increased labeling perimeter, mineral apposition rate, and tissue referent-bone formation rate in the secondary spongiosa and stimulated longitudinal bone growth as compared with the controls. Longer PTH treatment (75 days) further increased trabecular bone area, thickness, and number as compared with controls and groups given short-term PTH treatment (15 days). The bone formation indices in the secondary spongiosa of the longer-term treated rats were lower than those of the short-term treated group, but they were still higher than those of controls. Our findings indicate that PTH treatment stimulates cancellous bone formation, and restores and adds extra cancellous bone to the established, disuse-osteopenic proximal tibial metaphysis of female rats with continuously immobilized right hindlimbs. These results suggest that PTH may be useful in treating disuse-induced osteoporosis in humans.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; NASA Discipline Number 26-10; NASA Program Space Physiology and Countermeasures; Non-NASA Center

Mesh:

Substances:

Year:  1995        PMID: 7785472     DOI: 10.1002/jbmr.5650100322

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.

Authors:  Chad M Novince; Megan N Michalski; Amy J Koh; Benjamin P Sinder; Payam Entezami; Matthew R Eber; Glenda J Pettway; Thomas J Rosol; Thomas J Wronski; Ken M Kozloff; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Immobilization as the pathogenesis of osteoporosis: experimental and clinical studies.

Authors:  H Norimatsu; S Mori; J Kawanishi; Y Kaji; J Li
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin).

Authors:  J F Whitfield; P Morley; G E Willick; V Ross; J R Barbier; R J Isaacs; L Ohannessian-Barry
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

4.  Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat.

Authors:  P Oelzner; S Fleissner-Richter; R Bräuer; G Hein; G Wolf; T Neumann
Journal:  Inflamm Res       Date:  2010-03-20       Impact factor: 4.575

5.  Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.

Authors:  Yanfei L Ma; Henry U Bryant; Qingqiang Zeng; Allen Schmidt; Webster S S Jee; Masahiko Sato
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Prolonged unilateral disuse osteopenia 14 years post external fixator removal: a case history and critical review.

Authors:  Karen M Knapp; Ann V Rowlands; Joanne R Welsman; Kenneth M Macleod
Journal:  Case Rep Med       Date:  2010-04-21

7.  Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.

Authors:  Michael S Huang; Sean Morony; Jinxiu Lu; Zina Zhang; Olga Bezouglaia; Wendy Tseng; Sotirios Tetradis; Linda L Demer; Yin Tintut
Journal:  J Biol Chem       Date:  2007-05-22       Impact factor: 5.157

Review 8.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

9.  1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption.

Authors:  Peter Oelzner; Peter K Petrow; Gunter Wolf; Rolf Bräuer
Journal:  BMC Musculoskelet Disord       Date:  2014-10-14       Impact factor: 2.362

10.  Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization-induced bone loss.

Authors:  Lauren Harlow; Karim Sahbani; Jeffry S Nyman; Christopher P Cardozo; William A Bauman; Hesham A Tawfeek
Journal:  Physiol Rep       Date:  2017-09-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.